BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  New data at AACR 2026 demonstrate advancements in Cancerguard® Multi-Cancer Early Detection Test

  April 20, 2026

   · 

  4 min read
• Press Releases

  Cantargia Announces AACR 2026 Presentation of Study Design and Supportive Pre-Clinical Data for Investigator-Initiated Nadunolimab Study in MSS CRC

  April 20, 2026

   · 

  3 min read
• Press Releases

  New guidance from ACP says all average-risk females aged 50-74 should undergo biennial mammography screening for breast cancer

  April 20, 2026

   · 

  2 min read
• Press Releases

  Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 17, 2026

  April 20, 2026

   · 

  2 min read
• Press Releases

  Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

  April 20, 2026

   · 

  11 min read
• Press Releases

  ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting

  April 20, 2026

   · 

  6 min read
• Press Releases

  Meiji Holdings Co., Ltd. Highlights that Yogurt Containing Bacteria Metabolite Shows a Tendency Toward Higher Response When Added to Immune Checkpoint Inhibitor Therapy in People Living with Non-small Cell Lung Cancer

  April 20, 2026

   · 

  6 min read
• Press Releases

  Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types

  April 20, 2026

   · 

  9 min read
• Press Releases

  Theriva™ Biologics Announces Upcoming Presentation of Additional Data from the VIRAGE Phase 2b Clinical Trial of VCN-01 in Metastatic Pancreatic Cancer at AACR 2026 Annual Meeting

  April 20, 2026

   · 

  7 min read
• Press Releases

  Moderna to Present Phase 1/2 Data on Its Investigational Cancer Antigen Therapy mRNA-4359 as First-Line Therapy in Combination with Pembrolizumab in Locally Advanced or Metastatic Melanoma at the 2026 AACR Annual Meeting

  April 20, 2026

   · 

  6 min read